Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer

被引:32
|
作者
Gemer, O [1 ]
Segal, S [1 ]
Kopmar, A [1 ]
机构
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Barzilai Med Ctr, Dept Obstet & Gynecol, IL-78306 Ashkelon, Israel
关键词
CA; 125; cytoreduction; ovarian cancer;
D O I
10.1034/j.1600-0412.2001.080006583.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. Suboptimal cytoreduction of advanced ovarian cancer is related to initial tumor bulk which correlates with CA125 level. Methods. Retrospective record study of 40 patients with stage III ovarian cancer. The ability of a CA125 threshold level of 500 U/mL to predict suboptimal cytoreduction was determined. Results. Twenty-four (60%) of the patients were optimally cytoreduced. At the CA125 cut off level of 500 U/mL the sensitivity for predicting suboptimal debulking was 62% and specificity was 83%. Above a CA 125 level of 1500 U/mL none of the patients were optimally cytoreduced. Conclusions. More data are needed to determine the CA125 cut off level at which the standard approach of initial laparotomy and cytoreduction may be modified.
引用
收藏
页码:583 / 585
页数:3
相关论文
共 50 条
  • [21] Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian Cancer
    Ducoulombier, Simon
    Golfier, Francois
    Colomban, Olivier
    Benayoun, David
    Bolze, Pierre-Adrien
    Tod, Michel
    You, Benoit
    ANTICANCER RESEARCH, 2017, 37 (12) : 6879 - 6886
  • [22] Relationship of preoperative serum CA-125 to survival in epithelial ovarian carcinoma
    Geisler, JP
    Miller, GA
    Lee, TH
    Harwood, RM
    Wiemann, MC
    Geisler, HE
    JOURNAL OF REPRODUCTIVE MEDICINE, 1996, 41 (03) : 140 - 142
  • [23] Role of CA-125 in achieving optimal secondary cytoreduction
    Richardson, M. T.
    Routson, S.
    Karam, A. K.
    Dorigo, O.
    Diver, E.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 94 - 94
  • [24] The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer
    Barlow, TS
    Przybylski, M
    Schilder, JM
    Moore, DH
    Look, KY
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (02) : 496 - 500
  • [25] IS CA-125 MONITORING USEFUL IN PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA AND PREOPERATIVE NEGATIVE CA-125 SERUM LEVELS
    SEVELDA, P
    ROSEN, A
    DENISON, U
    BARRADA, M
    SPONA, J
    SALZER, H
    GYNECOLOGIC ONCOLOGY, 1991, 43 (02) : 154 - 158
  • [26] CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma
    Alcázar, JL
    Miranda, D
    Unanue, A
    Novoa, E
    Alemán, S
    Madariaga, L
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2004, 84 (02) : 173 - 174
  • [27] PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER
    Fagotti, A.
    Vizzielli, G.
    Tortorella, L.
    Fanfani, F.
    Costantini, B.
    Ferrandina, G.
    Gallotta, V.
    Alletti, S. Gueli
    Iodice, R.
    Scambia, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [28] PREOPERATIVE EVALUATION OF SERUM CA-125 LEVELS IN PATIENTS WITH PRIMARY EPITHELIAL OVARIAN-CANCER
    EINHORN, N
    BAST, RC
    KNAPP, RC
    TJERNBERG, B
    ZURAWSKI, VR
    OBSTETRICS AND GYNECOLOGY, 1986, 67 (03): : 414 - 416
  • [29] Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
    Feng, Li-Yuan
    Liao, Sheng-bin
    Li, Li
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [30] Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
    Li-yuan Feng
    Sheng-bin Liao
    Li Li
    Journal of Ovarian Research, 13